BIOASTER collaborates with ZYNNON to advance VOC-based detection and identification of pathogens in clinical and industrial microbiology settings
BIOASTER – Lyon, France, ZYNNON AG – Schindellegi, Switzerland, September 26, 2024
BIOASTER and ZYNNON are excited to announce a strategic collaboration focused on the innovative use of volatile organic compounds (VOCs) for the detection and identification of infections in clinical and industrial microbiology labs. This groundbreaking partnership aims to enhance diagnostic accuracy and efficiency for a wide range of infections caused by bacterial and fungal pathogens.
The technology stands out for its ability to directly measure VOCs released during the growth of these pathogens. This advancement reduces sample handling complexity and minimizes contamination risks, streamlining the diagnostic process. Recent laboratory tests performed at BIOASTER have demonstrated the effectiveness of the solution with key bacterial strains, including Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. By integrating pathogen detection and identification into a single unit, the system simplifies workflows and significantly enhances both accuracy and speed.
Télécharger le communiqué de presse complet ici